Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Heikenwalder

Showing results (31-40 of 263) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
NASH and Hepatocellular Carcinoma: Immunology and ImmunotherapyMatthias Pinter, David J Pinato, Pierluigi Ramadori, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Platelets in chronic liver disease, from bench to bedsidePierluigi Ramadori, Thomas Klag, Nisar Peter Malek, et al.
Journal of Molecular Neuroscience : MN|May 6, 2004
Current concepts and controversies in prion immunopathologyMathias Heikenwalder, Marco Prinz, Frank L Heppner, et al.
Current Protocols in Pharmacology|December 3, 2014
Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammationMarc Ringelhan, Florian Reisinger, Detian Yuan, et al.
Journal of Hepatology|January 20, 2020
Novel patient-derived preclinical models of liver cancerErin Bresnahan, Pierluigi Ramadori, Mathias Heikenwalder, et al.
Nature Immunology|January 31, 2018
The immunology of hepatocellular carcinomaMarc Ringelhan, Dominik Pfister, Tracy O'Connor, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 15, 2022
ReplySuchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Science (New York, N.Y.)|June 14, 2014
Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"Yuchen Xia, Julie Lucifora, Florian Reisinger, et al.
Frontiers in Oncology|December 6, 2021
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different MechanismsCristina Stefanescu, Merel Van Gogh, Marko Roblek, et al.
Trends in Cancer|March 6, 2021
Liver Inflammation and Hepatobiliary CancersValentina Leone, Adnan Ali, Achim Weber, et al.
Pageof 27

Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
NASH and Hepatocellular Carcinoma: Immunology and ImmunotherapyMatthias Pinter, David J Pinato, Pierluigi Ramadori, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Platelets in chronic liver disease, from bench to bedsidePierluigi Ramadori, Thomas Klag, Nisar Peter Malek, et al.
Journal of Molecular Neuroscience : MN|May 6, 2004
Current concepts and controversies in prion immunopathologyMathias Heikenwalder, Marco Prinz, Frank L Heppner, et al.
Current Protocols in Pharmacology|December 3, 2014
Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammationMarc Ringelhan, Florian Reisinger, Detian Yuan, et al.
Journal of Hepatology|January 20, 2020
Novel patient-derived preclinical models of liver cancerErin Bresnahan, Pierluigi Ramadori, Mathias Heikenwalder, et al.
Nature Immunology|January 31, 2018
The immunology of hepatocellular carcinomaMarc Ringelhan, Dominik Pfister, Tracy O'Connor, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 15, 2022
ReplySuchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Science (New York, N.Y.)|June 14, 2014
Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"Yuchen Xia, Julie Lucifora, Florian Reisinger, et al.
Frontiers in Oncology|December 6, 2021
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different MechanismsCristina Stefanescu, Merel Van Gogh, Marko Roblek, et al.
Trends in Cancer|March 6, 2021
Liver Inflammation and Hepatobiliary CancersValentina Leone, Adnan Ali, Achim Weber, et al.
Pageof 27